RSS   Newsletter   Contact   Advertise with us

Gene Walther to become CEO of Vortex BioSciences

Staff writer | London, United Kingdom | December 15, 2015
NetScientificDecember 15, 2015, London, United Kingdom - NetScientific plc appoints Gene Walther as CEO of Vortex BioSciences, and head of NetScientific's diagnostics franchise, of which Vortex is the key asset.
Mr. Walther will join on 4 January 2015. Mr. Walther brings over 20 years' impressive experience as a leading diagnostics executive with a proven track record in creating innovative and profitable growth strategies, globalising businesses and building strategic partnerships across the diagnostic, medical device and biotech spaces.

He has spent several years in the global health arena, most recently as a Consultant to the Paul G. Allen Family Foundation where he advised on their Ebola strategy with a particular focus on the role of diagnostics.

Prior to this, he was the Deputy Director, Diagnostics, for the Bill & Melinda Gates Foundation. He served as the Executive Chairman of the Board of GenturaDx where he led this start-up diagnostics firm through product and company development leading to a strategic acquisition by Luminex.

He spent over 11 years at Novartis as President and Global Head of Diagnostics and several roles at Chiron including President and Vice President across the diagnostics and global commercial development teams.

Mr. Walther will replace Vortex BioSciences interim CEO, Michael Boyce-Jacino who is leaving the Group and Board of Directors at the end of December 2015.

 LATEST MOVES FROM The United Kingdom